BRCA germline mutation test for all woman with ovarian cancer?
Abstract Background Delivering widespread BRCA testing to patients with ovarian cancer has been suggested by several scientists, recommended by professional societies and solicited by patients organizations. However, based on the lack of studies clearly demonstrating the cost-effectiveness of such a...
Main Authors: | A. V. Paradiso, M. Digennaro, M. Patruno, S. De Summa, S. Tommasi, I. Berindan-Neagoe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5829-4 |
Similar Items
-
Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01) -
Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing
by: Margherita Patruno, et al.
Published: (2021-09-01) -
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
by: Angelo Virgilio Paradiso, et al.
Published: (2020-08-01) -
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01) -
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
by: Tingyan Shi, et al.
Published: (2018-07-01)